Streetbeat News

Stock Prices

OSCR

Oscar Health (NYSE:OSCR) reported Q4 earnings with an EPS of $-0.66, beating estimates by 8.33% and showing a revenue increase of $436.87 million from the previous year. The company has a history of surpassing EPS estimates, leading to a positive impact on its share price the following day.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:35 pm

NWS

News Corp (NASDAQ:NWS) reported Q2 earnings with an EPS of $0.26, beating estimates by 36.84% and showing a revenue increase of $65.00 million from the previous year. Despite beating last quarter's EPS estimates, the share price dropped by 1.54% the following day.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:35 pm

QNST

QuinStreet (NASDAQ:QNST) reported Q2 earnings with a 20.0% beat on estimated EPS, reporting an EPS of $-0.04 versus an estimate of $-0.05. However, revenue was down $11.37 million from the same period last year. Despite beating last quarter's EPS estimate, the share price dropped by 4.12% the next day.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:35 pm

CENTA

Central Garden & Pet (NASDAQ:CENTA) reported Q1 earnings, surpassing estimated earnings by 105.88% with an EPS of $0.01 versus an estimate of $-0.17. Revenue increased by $6.87 million from the same period last year. Despite beating EPS estimates in the past, such performance was previously followed by a slight drop in share price.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:35 pm

MKSI

MKS Instruments (NASDAQ:MKSI) reported Q4 earnings with an EPS of $1.17, beating estimates by 39.29% but with a revenue decrease of $192M from the previous year. The company has a history of surpassing EPS estimates, as seen in the past quarters.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:35 pm

MOH

Molina Healthcare projects its 2024 total revenue to reach $39.6 billion, surpassing the estimated $38.17 billion. The company anticipates its premium revenue to hit around $38 billion, marking a 17% increase from 2023. However, its adjusted EPS is expected to be slightly below estimates at over $23.50, compared to the expected $23.57.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:34 pm

ALL

Allstate (NYSE:ALL) reported Q4 2023 earnings of $5.82 per share, surpassing the $3.99 estimate by 45.86%. Sales reached $14.83B, exceeding the $12.94B estimate by 14.61% and marking a 29.20% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:34 pm

OHI

Omega Healthcare Invts (OHI) reported Q4 2023 FFO of $0.68 per share, surpassing the $0.67 estimate. Sales reached $239.32M, exceeding the $233.82M forecast, marking a 65.22% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:34 pm

MCK

McKesson's stock price has declined following the announcement of its third-quarter financial results. The report indicates a negative market reaction to the earnings release.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:33 pm

FR

First Industrial Realty (NYSE:FR) reported Q4 2023 FFO of $0.63 per share, surpassing the $0.61 estimate, and sales of $157.28M, exceeding the $156.70M estimate. This represents a 5% increase in earnings and an 8.76% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 9:33 pm